Unpredictable disease fluctuations during the respiratory season make it difficult to differentiate between COVID-19, Flu, and RSV. And many cases go under reported.
For patients who feel sick, experienced symptoms may be nonspecific so it’s difficult to diagnose based on signs and symptoms alone. The challenge of differential diagnosis may lead to delays in clinical decision making, patient care and initiation of appropriate treatment and infection control measures. It is essential to accurately diagnose patients quickly to ensure they receive the best and most appropriate care.
That’s why Roche develops high-quality fully automated testing solutions, with our gold-standard PCR diagnostics systems, for the greatest confidence in assessing respiratory illnesses.
Get an early look at the solutions designed to help address your lab's needs now and well into the future.
*Turnaround times vary by assay.
For more information on these assays and more please contact us using the link below.
LEARN MORE ABOUT:
Gold-standard PCR diagnostics systems, for the greatest confidence in assessing respiratory illnesses.
ROCHE REPRESENTATIVE
Connect with a Roche representative on solutions for your lab and upcoming product launches.